Cannara Biotech "BUY"
Analysts at Haywood Securities initiated coverage on Cannara Biotech Inc with a "BUY" rating on Monday and a 12-month price target of $3.00
TSX Flat by Noon Easter Monday
Canada's main stock index changed little in choppy trading on Monday, as investors digested news that the U.S. and Iran were considering a proposed ?ceasefire that may bring the more than month-long Middle ...
AltaGas, Decisive Dividend, Extendicare at 52-Week Highs on News
AltaGas Ltd. (T.ALA) Hit a 52-Week High of $49.40. AltaGas will release its first quarter 2026 results on Thursday, April 30, before market open. A conference call and webcast will be held the same day ...
Air Canada Stock: Leadership Uncertainty Adds to the Turbulence
The stock market has been off to a volatile start to 2026. And for investors holding Air Canada (TSX:AC) stock, the turbulence is only intensifying. The company announced on Monday that Chief Executive ...
Analyst Ratings
Cannara Biotech "BUY"
Analysts at Haywood Securities initiated coverage on Cannara Biotech Inc with a "BUY" rating on Monday and a 12-month price target of $3.00
4/6/2026 11:59 AMLatest Videos
Crypto News
Research Reports
Edison Investment Research
Edison Investment Research
Edison Investment Research
Most Popular
Latest News
TSX Flat by Noon Easter Monday 3 hAltaGas, Decisive Dividend, Extendicare at 52-Week Highs on News 3 h
Air Canada Stock: Leadership Uncertainty Adds to the Turbulence 3 h
Stocks in Play: Oncolytics Biotech Inc 3 h
Is This Aerospace ETF the Ultimate Buy for Defense-Minded Investors? 3 h
This Retail Giant Just Boosted Its Dividend by 13% 3 h
Stocks in Play: Fairfax Financial Holdings Limited 4 h
Stocks in Play: Avino Silver & Gold Mines Ltd. 4 h
